| Dr Tommy Stephen Specht, DDS | |
|
522 13th St, Suite B, Paso Robles, CA 93446-7238 | |
| (805) 237-7773 | |
| (805) 238-1863 |
| Full Name | Dr Tommy Stephen Specht |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 522 13th St, Paso Robles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265735732 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 25842 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tommy Stephen Specht, DDS 522 13th St, Suite B, Paso Robles, CA 93446-7238 Ph: (805) 237-7773 | Dr Tommy Stephen Specht, DDS 522 13th St, Suite B, Paso Robles, CA 93446-7238 Ph: (805) 237-7773 |
News Archive
A new study posted to the bioRxiv* preprint server followed the adaptive immune response in convalescent patients from Swedish and Italian cohorts—which had earlier shown long-lasting adaptive immune responses to the G614 strain—for 15 months. Here, specific antibody levels and neutralizing antibody titers were tested against variants of concern (VOCs).
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme's efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant's operation for an extended period and certify compliance with FDA regulations.
Lophius Biosciences announced today that the USTPO has granted the U.S. Patent US 78293318 entitled "Use of urea-adjuvanted polypeptides for diagnosis, prophylaxis and therapy".
› Verified 7 days ago
Dr. Duffy Charles De Graw, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 922 Walnut Dr, Paso Robles, CA 93446 Phone: 805-226-9808 | |
A. Keyla Springe, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 143 Niblick Rd, Paso Robles, CA 93446 Phone: 805-226-8126 | |
Edith Pallencaoe, DDS Dentist Medicare: Medicare Enrolled Practice Location: 502 First St, Ste. B, Paso Robles, CA 93446 Phone: 805-239-9597 Fax: 805-239-4142 | |
Dr. Don R Miller, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1115 Vine St, Paso Robles, CA 93446 Phone: 805-238-2632 Fax: 805-238-6027 | |
Dr. Manouchehr Pouresmail, DMD, DDS, MSC Dentist Medicare: Not Enrolled in Medicare Practice Location: 106 Gateway Center Dr, Suite D, Paso Robles, CA 93446 Phone: 805-237-7668 Fax: 805-237-7663 | |
Dr. James Robert Oates, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7750 Sundance Trl, Paso Robles, CA 93446 Phone: 805-237-1523 | |
David Scott Shampain, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1920 Creston Rd, Suite B, Paso Robles, CA 93446 Phone: 805-239-2146 Fax: 805-239-9097 |